Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Current Leases (2016 - 2025)

Pharma-Bio Serv filings provide 15 years of Current Leases readings, the most recent being $28834.0 for Q4 2025.

  • On a quarterly basis, Current Leases fell 82.55% to $28834.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $28834.0, a 82.55% decrease, with the full-year FY2025 number at $28834.0, down 82.55% from a year prior.
  • Current Leases hit $28834.0 in Q4 2025 for Pharma-Bio Serv, down from $71362.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $169516.0 in Q2 2021 to a low of $11798.0 in Q1 2021.
  • Median Current Leases over the past 5 years was $143714.0 (2023), compared with a mean of $129420.8.
  • Biggest five-year swings in Current Leases: surged 1396.04% in 2021 and later crashed 82.55% in 2025.
  • Pharma-Bio Serv's Current Leases stood at $130060.0 in 2021, then rose by 8.3% to $140855.0 in 2022, then grew by 8.25% to $152474.0 in 2023, then grew by 8.35% to $165201.0 in 2024, then crashed by 82.55% to $28834.0 in 2025.
  • The last three reported values for Current Leases were $28834.0 (Q4 2025), $71362.0 (Q3 2025), and $113044.0 (Q2 2025) per Business Quant data.